Several presentations looked at the administration of IL-2 in patients who have viral suppression on currently stable ART therapy for a minimum of four months. When compared to a control, patients receiving IL-2 had a significant increase in CD4 with viral loads that remained undetectable. Changing medication to a maintenance therapy may require fewer pills and less complex regimens and may offer an improvement in dosing. Again, adherence is extremely important in maintaining durability of any medication regimen. Resistance Testing Up until recently, only genotyping information was available.
Many questions continue to hang in the forefront of everyone's mind.
Researchers, providers, and patients are still searching for the right initial medication regimen, how to improve adherence, and what to do with patients who are failing or intolerant to currently available medications. Perhaps as the World AIDS Conference 2000 rapidly approaches, more information will be presented that offers solutions to the current AIDS epidemic. Back to the Women Alive Spring 2000 Contents Page . This article was provided by Women Alive .